Physician profile
Ivan Lemas
NPI 1538794490
$537.88
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $53.28 · 2022: $390 · 2023: $70.33 · 2024: $24.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $94.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $94.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $261.35 | 2021-2024 | Nuzyra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.14 | 2022 | |
| Jazz Pharmaceuticals INC. | $35.48 | 2021-2022 | |
| Electromed, INC. | $31.41 | 2022 | |
| Insmed, INC. | $27.70 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.00 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $24.30 | 2022 | |
| Mallinckrodt Hospital Products INC. | $20.30 | 2022 | |
| Mylan Specialty L.P. | $18.67 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.53 | 2021 | |
| Lilly USA, LLC | $15.41 | 2022 | |
| Novo Nordisk INC | $13.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Lemas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.